Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Foresight Autonomous Holdings Ltd.FRSX · Entity 8311 | Chief Financial Officer | August 13, 2026 | August 17, 2026 |
| Gix Internet Ltd.GIXI · Entity 9041 | Director | August 31, 2026 | October 13, 2026 |
| QUANTUM X LABS INC.QXL · Entity 7082 | Director | August 21, 2026 | August 24, 2026 |
| Rail Vision Ltd.RVSN · Entity 7971 | Director | March 18, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Foresight Autonomous Holdings Ltd.
Report date August 13, 2026 · Filed August 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 13,142,887 |
Reported balance
After 2026-08-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-13 · Grant · Acquired 10,000,000 · Balance 13,142,887 F1: Includes 10,000,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through January 1, 2029. Each RSU represents the right to receive one Ordinary Share. F2: The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 10,000,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.
F2: The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.
Gix Internet Ltd.
Report date August 31, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 12,116 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 12,116 |
| Warrants to Purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $6.83 · Expires 2028-08-13 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-08-31 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: The exercise price of this warrant, originally denominated in New Israeli Shekels ("NIS") in the amount of NIS 21, is presented in the table in U.S. Dollars ("USD") based on the exchange rate reported by the Bank of Israel on October 7, 2026, which was NIS 3.0740 = USD 1.00. |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise price of this warrant, originally denominated in New Israeli Shekels ("NIS") in the amount of NIS 21, is presented in the table in U.S. Dollars ("USD") based on the exchange rate reported by the Bank of Israel on October 7, 2026, which was NIS 3.0740 = USD 1.00.
QUANTUM X LABS INC.
Report date August 21, 2026 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectBy Yoresh Capital Ltd. | 7,018 |
Reported balance
After 2026-08-21 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-08-21 · Purchase · Acquired 4,500 · Balance 7,018 F1: The price reported is a weighted average price. The reported securities were purchase in multiple transactions at prices ranging from $4.70 to $4.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range. F2: These securities are held by Yoresh Capital Ltd. The Reporting Person is the officer, sole director, chairman of the board of directors and controlling shareholder of Yoresh Capital Ltd. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. |
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 435,951 |
Reported balance
Holding disclosure · report date 2026-08-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 435,951 F3: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. The reported securities were purchase in multiple transactions at prices ranging from $4.70 to $4.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
F2: These securities are held by Yoresh Capital Ltd. The Reporting Person is the officer, sole director, chairman of the board of directors and controlling shareholder of Yoresh Capital Ltd. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes.
F3: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Rail Vision Ltd.
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 24,856 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 24,856 |
| Restricted Share UnitsSEC Table I · non-derivative | Direct | 3,714 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,714 F1: These restricted share units vest in 7 equal installments on a quarterly basis beginning on March 31, 2026, subject to the Reporting Person's continued service. F3: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Rail Vision Ltd. Amended Share Option Plan must be registered in the name of a trustee. |
| Restricted Share UnitsSEC Table I · non-derivative | Direct | 8,125 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 8,125 F2: These restricted share units vest in 9 equal installments on a quarterly basis beginning on March 31, 2026, subject to the Reporting Person's continued service. F3: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Rail Vision Ltd. Amended Share Option Plan must be registered in the name of a trustee. |
| Options to Purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $444.00 · Expires 2028-01-04 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F3: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Rail Vision Ltd. Amended Share Option Plan must be registered in the name of a trustee. |
| Options to Purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $444.00 · Expires 2032-05-11 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F3: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Rail Vision Ltd. Amended Share Option Plan must be registered in the name of a trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted share units vest in 7 equal installments on a quarterly basis beginning on March 31, 2026, subject to the Reporting Person's continued service.
F2: These restricted share units vest in 9 equal installments on a quarterly basis beginning on March 31, 2026, subject to the Reporting Person's continued service.
F3: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Rail Vision Ltd. Amended Share Option Plan must be registered in the name of a trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2026 Filed Aug 24, 2026 13:00 UTC | QUANTUM X LABS INC. QXL · Entity 7082 | PurchaseCommon Stock, par value $0.0001 per share | 4,500 | $4.77 | $21,465.00 |
DisclosureSEC source: 0001493152-26-039791 · ownership.xml · nonDerivative · entry 1 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Yoresh Capital Ltd. Disclosed balance after: 7,018 F1 · price: The price reported is a weighted average price. The reported securities were purchase in multiple transactions at prices ranging from $4.70 to $4.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range. F2 · ownership.nature: These securities are held by Yoresh Capital Ltd. The Reporting Person is the officer, sole director, chairman of the board of directors and controlling shareholder of Yoresh Capital Ltd. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 20:01 UTC | Foresight Autonomous Holdings Ltd. FRSX · Entity 8311 | GrantOrdinary Shares | 10,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-038734 · ownership.xml · nonDerivative · entry 1 Yoresh Eliyahu · CIK 0001939392 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,142,887 F1 · shares: Includes 10,000,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through January 1, 2029. Each RSU represents the right to receive one Ordinary Share. F2 · balance_after: The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date. Read SEC document |
| May 31, 2026 Filed Jun 1, 2026 20:30 UTC | QUANTUM X LABS INC. QXL · Entity 7082 | OtherPre-Funded Warrant to purchase common stock · Derivative | 88,675 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-026636 · ownership.xml · derivative · entry 3 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 88,675 shares Expires not disclosed F2 · derivative.expiration_date: The Pre-Funded Warrants will not expire until exercised in full. Read SEC document |
| May 31, 2026 Filed Jun 1, 2026 20:30 UTC | QUANTUM X LABS INC. QXL · Entity 7082 | OtherCommon Stock, par value $0.0001 per share | 88,675 | $0.00 | $8.87 |
DisclosureSEC source: 0001493152-26-026636 · ownership.xml · nonDerivative · entry 1 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 435,951 F1 · price: On May 31, 2026, the Reporting Person exercised a pre-funded warrant to purchase 88,675 shares of common stock of Quantum X Labs Inc. The Reporting Person paid the exercise price on a cashless basis, which did not result in the withholding of any shares. Read SEC document |
| March 04, 2026 Filed Mar 12, 2026 13:21 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchasePre-Funded Warrant to purchase common stock · Derivative | 88,675 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001493152-26-009797 · ownership.xml · derivative · entry 3 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,675 Underlying: Common Stock · 88,675 shares Expires not disclosed F1 · shares: On March 4, 2026, the Reporting Person acquired (i) 179,159 shares of common stock of Viewbix Inc. ("Common Stock") and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 88,675 shares of Common Stock, in exchange for the Reporting Person's shares in Quantum X Labs Ltd. ("Quantum"), pursuant to a Securities Exchange Agreement dated December 15, 2025 by and between the Issuer, Quantum and shareholders of Quantum, which included the Reporting Person (the "Securities Exchange Agreement'). The transactions contemplated by the Securities Exchange Agreement were pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. F1 · price: On March 4, 2026, the Reporting Person acquired (i) 179,159 shares of common stock of Viewbix Inc. ("Common Stock") and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 88,675 shares of Common Stock, in exchange for the Reporting Person's shares in Quantum X Labs Ltd. ("Quantum"), pursuant to a Securities Exchange Agreement dated December 15, 2025 by and between the Issuer, Quantum and shareholders of Quantum, which included the Reporting Person (the "Securities Exchange Agreement'). The transactions contemplated by the Securities Exchange Agreement were pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. F3 · derivative.expiration_date: The Pre-Funded Warrants will not expire until exercised in full. Read SEC document |
| March 04, 2026 Filed Mar 12, 2026 13:21 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchaseCommon Stock, par value $0.0001 per share | 179,159 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-26-009797 · ownership.xml · nonDerivative · entry 1 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,276 F1 · shares: On March 4, 2026, the Reporting Person acquired (i) 179,159 shares of common stock of Viewbix Inc. ("Common Stock") and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 88,675 shares of Common Stock, in exchange for the Reporting Person's shares in Quantum X Labs Ltd. ("Quantum"), pursuant to a Securities Exchange Agreement dated December 15, 2025 by and between the Issuer, Quantum and shareholders of Quantum, which included the Reporting Person (the "Securities Exchange Agreement'). The transactions contemplated by the Securities Exchange Agreement were pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. F1 · price: On March 4, 2026, the Reporting Person acquired (i) 179,159 shares of common stock of Viewbix Inc. ("Common Stock") and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 88,675 shares of Common Stock, in exchange for the Reporting Person's shares in Quantum X Labs Ltd. ("Quantum"), pursuant to a Securities Exchange Agreement dated December 15, 2025 by and between the Issuer, Quantum and shareholders of Quantum, which included the Reporting Person (the "Securities Exchange Agreement'). The transactions contemplated by the Securities Exchange Agreement were pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 21:00 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | GiftCommon Stock, par value $0.0001 per share | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-026728 · ownership.xml · nonDerivative · entry 2 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,117 F3 · shares: This transaction involved the Reporting Person's gift of 100,000 shares of the Issuer's common stock to his son. The Reporting Person disclaims beneficial ownership of the securities held by his son, and this Form 4 shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 21:00 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchaseCommon Stock, par value $0.0001 per share | 260,000 | $1.00 | $260,000.00 |
DisclosureSEC source: 0001641172-25-026728 · ownership.xml · nonDerivative · entry 1 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,117 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on September 3, 2025, pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock in the Private Placement was $1.00. Read SEC document |
| July 11, 2025 Filed Jul 14, 2025 20:30 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchaseWarrant to purchase common stock · Derivative | 5,144 | $4.86 Strike: $4.74 | $24,999.84 |
DisclosureSEC source: 0001641172-25-019520 · ownership.xml · derivative · entry 4 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,144 Underlying: Common Stock · 5,144 shares Expires 2031-01-14 F5 · shares: The warrants to purchase common stock (the "Warrants") reported in this row represent Warrants that were acquired in the Private Placement. F2 · price: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 11, 2025, pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). Read SEC document |
| July 11, 2025 Filed Jul 14, 2025 20:30 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchaseCommon Stock, par value $0.0001 per share | 5,144 | $4.86 | $24,999.84 |
DisclosureSEC source: 0001641172-25-019520 · ownership.xml · nonDerivative · entry 2 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,117 F2 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 11, 2025, pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F3 · price: The purchase price per share of common stock and associated common warrant in the Private Placement was $4.86. Read SEC document |
| June 17, 2025 Filed Jul 14, 2025 20:30 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | GiftCommon Stock, par value $0.0001 per share | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-019520 · ownership.xml · nonDerivative · entry 1 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,973 F1 · shares: The shares of common stock reported in this row represent shares of that were acquired by the Reporting Person as a gift for no consideration. Read SEC document |
| June 18, 2024 Filed Mar 21, 2025 11:57 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchaseWarrant to purchase common stock · Derivative | 2,518 | $1.00 Strike: $1.00 | $2,518.00 |
DisclosureSEC source: 0001493152-25-011078 · ownership.xml · derivative · entry 2 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Yoresh Capital Ltd. Disclosed balance after: 12,604 Underlying: Common Stock · 2,518 shares Expires 2027-06-18 F2 · price: The warrants to purchase common stock, par value $0.0001 per share was issued by the Company to the reporting person, upon the conversion of outstanding interest, at a conversion rate of $1.00 due under a loan provided by the reporting person pursuant to the Facility Agreement. F3 · balance_after: Includes (i) 2,568 shares of common stock, previously issued to the reporting person and (ii) a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025 held by Yoresh Capital Ltd. F4 · ownership.nature: Eli Yoresh is the officer, sole director, chairman of the board of directors and controlling shareholder of Yoresh Capital Ltd. Read SEC document |
| June 18, 2024 Filed Mar 21, 2025 11:57 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchaseCommon Stock, par value $0.0001 per share | 2,518 | $1.00 | $2,518.00 |
DisclosureSEC source: 0001493152-25-011078 · ownership.xml · nonDerivative · entry 1 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Yoresh Capital Ltd. Disclosed balance after: 12,604 F1 · price: The shares of common stock were issued by the Company to the reporting person upon the conversion of outstanding interest, at a conversion rate of $1.00, due under a loan provided by the reporting person pursuant to the facility agreement between the Company, the reporting person and the other lenders listed therein (the "Facility Agreement"). F3 · balance_after: Includes (i) 2,568 shares of common stock, previously issued to the reporting person and (ii) a warrant to purchase 5,000 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025 held by Yoresh Capital Ltd. F4 · ownership.nature: Eli Yoresh is the officer, sole director, chairman of the board of directors and controlling shareholder of Yoresh Capital Ltd. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 22:12 UTC | QUANTUM X LABS INC. VBIX · Entity 7082 | PurchaseWarrant to purchase common stock · Derivative | 20,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001493152-23-044424 · ownership.xml · derivative · entry 2 Yoresh Eliyahu · CIK 0001939392 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Yoresh Capital Ltd. Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2025-12-31 F2 · security: The warrant to purchase common stock, par value $0.0001 per share, was issued by the Company to the reporting person pursuant to a loan agreement between Viewbix Ltd., a wholly owned subsidiary of the Company, the reporting person and the other lenders listed therein. F2 · ownership.direct: The warrant to purchase common stock, par value $0.0001 per share, was issued by the Company to the reporting person pursuant to a loan agreement between Viewbix Ltd., a wholly owned subsidiary of the Company, the reporting person and the other lenders listed therein. F3 · ownership.nature: The reporting person is the sole director and officer of Yoresh Capital Ltd. The reporting person has a beneficial ownership interest in Yoresh Capital Ltd. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.